A study published in the British Medical Journal confirms an earlier, highly controversial finding by the Cochrane Database Review (2009), which concluded that breast screeningsare likely causing more harm than good.1
Published last month (Dec. 2011) and titled "Possible net harms of breast cancer screening: updated modeling of Forrest report," its authors concluded: "This analysis supports the claim that the introduction of breast cancer screening might have caused net harm for up to 10 years after the start of screening."
The latest news coverage on breast cancer screening overlooks critical issues, conflating cancer risk with mortality and failing to address the harms of overdiagnosis and overtreatment.
For over a decade, GreenMedInfo has championed the classification of ductal carcinoma in situ (DCIS) as something other than cancer, standing firm against the tide of overdiagnosis and overtreatment.
The study investigated the natural history of breast cancers detected in the Swedish mammography screening program between 1986 to 1990, involving 650,000 women.
A groundbreaking study published in the Annals of Internal Medicine has revealed a significant preference among women in their 40s to delay mammography screening when provided with comprehensive information about its benefits and risks. This research challenges recent recommendations from the U.S. Preventive Services Task Force (USPSTF) and underscores the importance of informed consent in healthcare decisions.1